Fisher & Paykel Healthcare Corporation
Fisher & Paykel Healthcare is a global leader in the design, manufacturing and marketing of medical devices, with a focus on innovative products for respiratory care, acute care, surgery and obstructive sleep apnoea.
Products are manufactured in NZ and Mexico and are primarily sold to hospitals and healthcare facilities around the world through an extensive distribution network.
F&P is listed on both the NZX and ASX and is one of the largest listed companies on the NZX in terms of market capitalisation. The company employs over 5,000 people and is a leader in research and development, investing more than $100 million a year into innovation. Lewis Gradon took over as CEO in 2016.
Title | Date | Type |
---|---|---|
SPH Notice – Pinnacle Investment Management Group Limited | Tue, May 17 2022 08:39 am | SHINTR |
Notification of Issue of Securities | Thu, May 12 2022 01:59 pm | SECISSUE |
Notification of Issue of Securities | Tue, Apr 19 2022 04:30 pm | SECISSUE |
Fisher & Paykel Healthcare announces 2022 Investor Day | Thu, Apr 14 2022 10:50 am | GENERAL |
FPH to announce full year results on 25 May 2022 | Thu, Apr 14 2022 10:49 am | GENERAL |
Notification of Issue of Securities - North America ESPP | Thu, Apr 07 2022 04:03 pm | SECISSUE |
Notification of Issue of Securities | Fri, Mar 25 2022 02:37 pm | SECISSUE |
Fisher & Paykel Healthcare provides FY22 revenue guidance | Wed, Mar 23 2022 08:30 am | MKTUPDTE |
D&O Ongoing Disclosure Notices | Mon, Mar 07 2022 02:06 pm | SHINTR |
Notification of Issue of Securities - NZ ESPS | Tue, Mar 01 2022 04:59 pm | SECISSUE |

Date | Name | No. Held | % | Current |
---|---|---|---|---|
27/09/21 | Mitsubishi UFJ Financial Group, Inc | 35,213,089 | 5.05 | 6.10 |
03/08/21 | The Vanguard Group, Inc. | 21,144,194 | 5.26 | 3.67 |
13/07/21 | BlackRock, Inc. and related bodies | 37,908,016 | 5.01 | 6.58 |
17/08/20 | The Capital Group Companies, Inc. | 27,621,429 | 5.36 | 4.80 |
04/12/17 | Bennelong Funds Management Group Pt | 28,250,795 | 5.00 | 4.95 |
22/06/17 | Northcape Capital Pty Limited | 28,174,622 | 5.01 | 4.96 |
Date | Name | No. Held | % | Details | Other |
---|---|---|---|---|---|
07/03/22 | Lyndal Jane York | 93,480 | - | - | - |
07/03/22 | Lewis George Gradon | 936,529 | - | - | - |
09/12/21 | Lisa Margaret McIntyre | 4,400 | - | - | - |
09/03/21 | Scott A. St John | 21,000 | - | - | - |
06/07/20 | Michael Grenfell Daniel | 900,168 | - | - | - |
15/10/19 | Geraldine Celia McBride | 1,262 | - | - | - |
08/01/19 | Antony John Carter | 76,102 | - | - | - |
08/01/19 | Donal ODwyer | 68,569 | - | - | - |
13/11/18 | Neville John Mitchell | 7,200 | - | - | - |
12/07/18 | Arthur Morris | 29,695 | - | - | - |
29/12/17 | Antony George Barclay | 150,000 | - | - | - |
21/12/17 | Anthony Beverley | 74,962 | - | - | - |
01/06/17 | Philippa Greenwood | 3,800 | - | - | - |
profit2021 | profit2022 | eps2021 | dps2021 | sales2021 | ebit2021 | ebitda2021 | |
---|---|---|---|---|---|---|---|
mean | 386.0 | 392.5 | 66.4 | 43.2 | 1,698.0 | 504.4 | 600.9 |
high | 396.1 | 462.4 | 67.6 | 47.3 | 1,698.0 | 504.4 | 604.7 |
low | 375.8 | 322.6 | 65.1 | 39.0 | 1,698.0 | 504.4 | 597.1 |
sample | 2 | 2 | 2 | 2 | 1 | 1 | 2 |